Pinhua Pan

415 citations
9 papers · 324 indexed · h-index 7
Topics
Immune Response and Inflammation (7 papers)Neutrophil, Myeloperoxidase and Oxidative Mechanisms (3 papers)Respiratory Support and Mechanisms (2 papers)
Partner nations
ChinaUnited States

In The Last Decade

Pinhua Pan

9 papers receiving 324 citations

Peers

Pinhua Pan
Comparison fields: 5 of 66
  • Immunology 222
  • Molecular Biology 113
  • Pulmonary and Respiratory Medicine 81
  • Epidemiology 38
  • Infectious Diseases 35
Replace Haosi Li with:
Haosi Li China
Haixia Kang China
Mayra Pinilla-Vera United States
Amy Livesey United Kingdom
Kylie Belchamber United Kingdom
Momina Khan Canada
Kristie L. Hilliard United States
Patrick Wijten Qatar
Eri Allen United States
Hasan Halit Öz Germany
Pinhua Pan relative to Haosi Li China Haosi Li's profile →
Citations per field
00.5×1.5×
Haosi Li · 1×
Citations per year

Countries citing papers authored by Pinhua Pan

Since Specialization
Citations

This map shows the geographic impact of Pinhua Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pinhua Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pinhua Pan more than expected).

Fields of papers citing papers by Pinhua Pan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pinhua Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pinhua Pan. The network helps show where Pinhua Pan may publish in the future.

Co-authorship network of co-authors of Pinhua Pan

This figure shows the co-authorship network connecting the top 25 collaborators of Pinhua Pan. A scholar is included among the top collaborators of Pinhua Pan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pinhua Pan. Pinhua Pan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
#WorkIndexed citations
1 3
2 6
3 31
4 38
5 204
6 4
7 16
8 9
9
Interferon regulatory factor-1 mediates the release of high mobility group box-1 in endotoxemia in mice.
13

About Pinhua Pan

Pinhua Pan is a scholar working on Immunology, Microbiology and Clinical Biochemistry, having authored 9 papers that have together received 324 indexed citations. Recurring topics across this work include Immune Response and Inflammation (7 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (3 papers) and Respiratory Support and Mechanisms (2 papers). The work is most often cited by research in Immunology (222 citations), Pulmonary and Respiratory Medicine (81 citations) and Critical Care and Intensive Care Medicine (11 citations). Pinhua Pan has collaborated with scholars based in China and United States. Frequent co-authors include Lemeng Zhang, Xiaoli Su, Haitao Li, Minhui Dai, Haosi Li, Dongdong Wu, Yi Li, Shuai Liu, Chengping Hu and Allan Tsung. Their work appears in journals such as Scientific Reports, CHEST Journal and BioMed Research International.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026